trending Market Intelligence /marketintelligence/en/news-insights/trending/vlyi662AT0k7RP3LelPbIQ2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Northwest Biotherapeutics issues common stock, warrants in private placement

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Northwest Biotherapeutics issues common stock, warrants in private placement

Northwest Biotherapeutics Inc. sold 5.0 million common shares at 20 cents apiece to an unaffiliated investor.

The company also issued to the investor 2.5 million class D warrants exercisable at 23 cents per share for a period of two years, and 2.5 million class D warrants exercisable at 30 cents per share for a period of two years, for an aggregate of $1.0 million.